Terms: = Colorectal cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
87 results:
1. Prognostic value of the fat-free mass index-based cachexia index in patients with colorectal cancer.
Qin Y; Xie H; Liu T; Zhang H; Liu C; Li X; Bu Z; Liu X; Lin S; Chen Y; Zheng X; Zhao H; Shi J; Shi H
Sci Rep; 2024 Oct; 14(1):24390. PubMed ID: 39420045
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer.
Jiang JZ; Qiao YB; Zhu XR; Gu QH; Lu JJ; Ye ZY; Xu L; Liu YY
Cell Death Dis; 2024 Sep; 15(9):699. PubMed ID: 39349432
[TBL] [Abstract] [Full Text] [Related]
3. Association of CD8
Yang J; Ding X; Fang Z; Wu S; Yuan M; Chen R; Xu Q; Gao X; Wu H; Chen L; Zheng X; Jiang J
BMC Cancer; 2024 Jul; 24(1):869. PubMed ID: 39030523
[TBL] [Abstract] [Full Text] [Related]
4. Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated cancers in Patients With Type 2 Diabetes.
Wang L; Xu R; Kaelber DC; Berger NA
JAMA Netw Open; 2024 Jul; 7(7):e2421305. PubMed ID: 38967919
[TBL] [Abstract] [Full Text] [Related]
5. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
[TBL] [Abstract] [Full Text] [Related]
6. [Relationship Between Tim-3 and Galectin-9 Expression Levels, Clinical Pathological Characteristics, and prognosis in Patients After Radical Resection of colorectal cancer].
Zhang Y; Deng D; Yin W; Luo J; Liu J; Xie C; Ji X; Ma L; Zhang L; Xia X; Cheng S; Huang A; Yang F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):375-382. PubMed ID: 38645842
[TBL] [Abstract] [Full Text] [Related]
7. BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis.
Petrelli F; Arru M; Colombo S; Cavallone M; Cribiu' FM; Villardita V; Floris P; Digiesi L; Severgnini G; Moraes MT; Conti B; Celotti A; Viti M; Sozzi A
Eur J Surg Oncol; 2024 Jun; 50(6):108306. PubMed ID: 38603866
[TBL] [Abstract] [Full Text] [Related]
8. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
[TBL] [Abstract] [Full Text] [Related]
9. miR-330-5p Suppress Cell Growth and Invasion via Disrupting HSF4-mediated MACC1/STAT3 Pathway in colorectal cancer.
Liu J; Yue K; Yang J; Bi C; Zhang Y; Zhang W
Front Biosci (Landmark Ed); 2024 Feb; 29(2):53. PubMed ID: 38420805
[TBL] [Abstract] [Full Text] [Related]
10. High-tissue FRMD6 expression predicts better outcomes among colorectal cancer patients.
von Koskull A; Hagström J; Haglund C; Kaprio T; Böckelman C
Biomarkers; 2024 May; 29(3):127-133. PubMed ID: 38385211
[TBL] [Abstract] [Full Text] [Related]
11. Long-term outcomes of endoscopic or surgical resection in T1 colorectal cancer patients: a retrospective cohort study.
Song S; Dou L; Zhang Y; Liu X; Liu Y; He S; Wang G
Surg Endosc; 2024 Mar; 38(3):1499-1511. PubMed ID: 38242989
[TBL] [Abstract] [Full Text] [Related]
12. A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.
Feng C; Li Y; Tai Y; Zhang W; Wang H; Lian S; Jin-Si-Han EE; Liu Y; Li X; Chen Q; He M; Lu Z
Sci Rep; 2023 Nov; 13(1):19297. PubMed ID: 37935721
[TBL] [Abstract] [Full Text] [Related]
13. Second primary colorectal cancer in adults: a SEER analysis of incidence and outcomes.
Lun W; Luo C
BMC Gastroenterol; 2023 Jul; 23(1):253. PubMed ID: 37495987
[TBL] [Abstract] [Full Text] [Related]
14. Somatic mutation profiling, tumor-infiltrating leukocytes, tertiary lymphoid structures and PD-L1 protein expression in HER2-amplified colorectal cancer.
Liu XT; Kou ZY; Zhang H; Dong J; Zhang JH; Peng YJ; Ma SM; Liang L; Meng XY; Zhou Y; Yang J
PeerJ; 2023; 11():e15261. PubMed ID: 37151285
[TBL] [Abstract] [Full Text] [Related]
15. Single-Cell Sequencing-Based Validation of T Cell-Associated Diagnostic Model Genes and Drug Response in Crohn's Disease.
Dai Z; Zhang J; Xu W; Du P; Wang Z; Liu Y
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047025
[TBL] [Abstract] [Full Text] [Related]
16. Changing trends, clinicopathological characteristics, surgical treatment patterns, and prognosis of schistosomiasis-associated versus non-schistosomiasis-associated colorectal cancer: a large retrospective cohort study of 31 153 cases in Shanghai, China (2001-2021).
Zheng N; Wang H; Yu Q; Wang C; Bai CG; Pan AF; Jiang J; Lu J; Dai SM; Mei Z; Zhang W; Gao XH
Int J Surg; 2023 Apr; 109(4):772-784. PubMed ID: 36999800
[TBL] [Abstract] [Full Text] [Related]
17. Has_circ_0071803 promotes colorectal cancer progression by regulating miR-330-5p/MAPK signaling pathway.
Huang L; Dou G; Lu J; Chen Z; Wang J
Histol Histopathol; 2023 Dec; 38(12):1443-1451. PubMed ID: 36856372
[TBL] [Abstract] [Full Text] [Related]
18. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
[TBL] [Abstract] [Full Text] [Related]
19. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic cancer: A Propensity Score Matching Analysis.
Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
[TBL] [Abstract] [Full Text] [Related]
20. The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer.
Su YT; Chen JW; Chang SC; Jiang JK; Huang SC
Sci Rep; 2022 Nov; 12(1):20075. PubMed ID: 36418865
[TBL] [Abstract] [Full Text] [Related]
[Next]
